You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 137 No. 9, September 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  The Cutting Edge: Challenges in Medical and Surgical Therapeutics
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •HIV/AIDS
 •Dermatology
 •Dermatology, Other
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment of Kaposi Sarcoma With Oral Administration of Shark Cartilage in a Human Herpesvirus 8–Seropositive, Human Immunodeficiency Virus–Seronegative Homosexual Man

Joseph D. Hillman, BS; Albert T. Peng, MD; Anita C. Gilliam, MD, PhD; Scot C. Remick, MD
From the Departments of Pathology (Mr Hillman) and Dermatology (Drs Peng and Gilliam) and the Division of Hematology/Oncology in the Department of Medicine (Dr Remick), University Hospitals of Cleveland, Case Western Reserve University, Cleveland, Ohio.

Arch Dermatol. 2001;137:1149-1152.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

REPORT OF A CASE

A 45-year-old white man presented with a 21/2-year history of a bruiselike area on the arch of his right foot (Figure 1). A skin biopsy specimen of the lesion revealed Kaposi sarcoma (KS) (Figure 2), with slitlike vascular spaces that were accentuated by CD34 immunostaining (Figure 3).


 
Figure appears in full text version.
Figure 1. A, Erythematous patch of Kaposi sarcoma on the patient's right mid instep in 1997. B, Patch has faded significantly in color by 1999.



 
Figure appears in full text version.
Figure 2. Sections of skin in 1997 (A) and 1999 (B) showing decreased numbers of small vessels in papillary dermis (hematoxylin-eosin, original magnification x40).



 
Figure appears in full text version.
Figure 3. Immunostaining for CD34 to accentuate vessels of Kaposi sarcoma shows diminished numbers and prominence of vascular spaces in 1997 (A) compared with 1999 (B). Immunostaining was performed . . . [Full Text of this Article]


THERAPEUTIC CHALLENGE

SOLUTION

COMMENT



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.